ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0629

Negative Affect, Anxiety and Fatigue Moderate the Association Between Pain Intensity and Physical Function in People with Systemic Sclerosis

Daniel Whibley1, Yen Chen1, Anna Kratz1, Dinesh Khanna1 and Susan Murphy2, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Plymouth, MI

Meeting: ACR Convergence 2023

Keywords: Anxiety, Fatigue, pain, physical function, Scleroderma

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 12, 2023

Title: (0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Pain is a common symptom of systemic sclerosis (SSc), affecting over 80% of those living with the condition, with over a third experiencing pain of moderate or severe intensity. Pain intensity is strongly associated with physical functioning in SSc, however psychosocial moderators of this association are understudied. If modifiable psychosocial factors decouple the pain intensity-physical functioning association, addressing them may help diminish physical limitations attributable to SSc-related pain. Accordingly, this study examined psychosocial factors as potential moderators of the pain intensity-physical function association in SSc.

Methods: This cross-sectional observational study used baseline data from a trial examining the effectiveness of a web- and app-based intervention for fatigue management for people with SSc (ClinicalTrials.gov identifier NCT04908943). Participants were >18 years old with any SSc subtype, with a mean score >4 on the Fatigue Severity Scale. A questionnaire battery captured information about demographic, clinical and psychosocial factors. Pain intensity was assessed using the PROMIS Global Pain item (average pain past 7 days; 0-10 Numeric Rating Scale); physical function was assessed with the PROMIS short-form v2.0 Physical Function 4a. Psychosocial factors examined as potential moderators were positive and negative affect (Positive and Negative Affect Schedule), resilience (Connor-Davidson Resilience Scale), and PROMIS measures of anxiety, depression, fatigue, sleep disturbances, and self-efficacy. Linear regression was used to quantify the association between pain intensity and physical function, with interaction terms added for each moderator in separate models, adjusted for age, SSc subtype, and disease duration.

Results: Of 174 people recruited to the trial, 173 were randomized and included. 93% were female, sample mean age 54.5 (standard deviation (SD) 11.7). Most were white (83%), non-Hispanic/non-Latino (87%), and married (65%). 47% had diffuse cutaneous SSc, 35% limited,13% overlap, and 5% other/unsure. Mean (SD) pain intensity was 4.9 (2.3) and mean physical function T-score was 38.5 (1.2 SD below the general US population). There was a linear association between pain intensity and physical function, with pain intensity explaining 31% of variability in physical functioning, adjusted for age, SSc subtype, and disease duration. Statistically significant interaction effects were identified for level of negative affect, anxiety, and fatigue. In all cases, higher psychosocial symptom levels were associated with a stronger, negative association between pain intensity and physical functioning.

Conclusion: Negative affect, anxiety and fatigue moderated the association between pain intensity and physical functioning. Compared to those with lower levels of these psychosocial symptoms, those with higher levels experienced poorer physical functioning at higher pain intensities. If replicated, these findings would support longitudinal studies to examine whether addressing high levels of negative affect, anxiety and fatigue improve physical functioning of people with SSc-related pain.


Disclosures: D. Whibley: None; Y. Chen: None; A. Kratz: American Psychological Association, 12, Editor, Happify/Twill, 2; D. Khanna: AbbVie, 12, DSMB, AstraZeneca, 2, Boehringer-Ingelheim, 2, Bristol-Myers Squibb, 2, 5, CSL Behring, 2, Genentech, 2, Horizon Therapeutics, 2, 5, Janssen, 2, 6, Pfizer, 5, Prometheus, 2; S. Murphy: None.

To cite this abstract in AMA style:

Whibley D, Chen Y, Kratz A, Khanna D, Murphy S. Negative Affect, Anxiety and Fatigue Moderate the Association Between Pain Intensity and Physical Function in People with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/negative-affect-anxiety-and-fatigue-moderate-the-association-between-pain-intensity-and-physical-function-in-people-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/negative-affect-anxiety-and-fatigue-moderate-the-association-between-pain-intensity-and-physical-function-in-people-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology